JAGX: Jaguar Health, Inc. Company Short-Term Debt

Symbol and logo of brand Jaguar Animal Health (JAGX)

The market dynamics of Jaguar Health, Inc. (JAGX) show a current level of 0.12. Jaguar Health, Inc. is developing partnerships with oncology and veterinary centers to promote Mytesi globally. The company relies on the release of plant-based diarrhea treatments for humans and animals. Simultaneously, the R&D division is conducting final clinical trials of crofelemer, expanding the drug's range of applications for chemotherapy.

JAGX (Jaguar Health Inc) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Analytical breakdowns for Jaguar Health, Inc.

- current quotes and average value forecast:
Price Chart Jaguar Health|JAGX - Fair Value Consensus
- market capitalization information:
Market Value Jaguar Health, Inc.|JAGX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Jaguar Health|JAGX - Book Capitalization|Market Cap to Net Assets Ratio jaguar.health|JAGX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Jaguar Health, Inc.|JAGX - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Jaguar Health, Inc.|JAGX - Company Total Debt Obligations|Debt to Book Value Jaguar Health, Inc.|JAGX - Amount of Long-Term Liabilities|Company Short-Term Debt Jaguar Health|Quick Ratio jaguar.health
- net income and valuation multiples indicators:
JAGX - Net Profit
Fundamental company analysis:Jaguar Health - JAGX
Manufactured products of Jaguar Health Corp

Institutional capital assesses the attractiveness of Jaguar Health, Inc. (JAGX) through the lens of the company's ability to service current liabilities amid biopharmaceutical market volatility. The dynamics of short-term financial liabilities reflect the total sum of all debts maturing within one year, which becomes a critical indicator of solvency and overall asset reliability given the vulnerability of raw material supply chains.

Who Jaguar Health, Inc. competes with

PHAT - Company Short-Term Debt|Company Short-Term Loans and Borrowings TERN (Terns Pharma)|ironwoodpharma.com (IRWD) - Company Short-Term Debt|Company Current Liabilities Curanex Pharmaceuticals|IMRN (Immuron Ltd) - Company Short-Term Debts|Company Short-Term Debts evokepharma.com|Company Current Liabilities ENTO (Entero Therapeutics, Inc.)|RDHL (redhillbio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PALI (Palisade Bio)|Short-Term Indebtedness Biora Therapeutics, Inc|Morphic Holding, Inc. - Company Short-Term Debts